Phoenix Biotech Acquisition Corp.
NASDAQ:PBAX
5.85 (USD) • At close February 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||
Current Assets: | ||||||||||
Cash & Cash Equivalents
| 0.119 | 0.105 | 0.178 | 0.476 | 0.508 | 0.554 | 0.79 | 0.001 | 0 | 0 |
Short Term Investments
| 8.33 | 13.897 | 14.032 | 0 | 179.645 | 178.791 | 178.5 | 0 | 0 | 0 |
Cash and Short Term Investments
| 0.119 | 0.105 | 0.178 | 0.476 | 0.508 | 0.554 | 0.79 | 0.001 | 0 | 0 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.022 | 0.108 | 0.22 | 0.225 | 0.277 | 0.292 | 0.307 | 0 | 0.024 | 0.024 |
Total Current Assets
| 8.471 | 14.11 | 14.43 | 42.367 | 0.785 | 0.846 | 1.098 | 0.001 | 0.024 | 0.024 |
Non-Current Assets: | ||||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 14.032 | 0 | 179.645 | 178.791 | 178.526 | 0.178 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | -0 | 0 | 0.021 | 0.087 | 0.153 | 0 | 0.277 | 0.001 |
Total Non-Current Assets
| 0 | 0 | 14.032 | 0 | 179.666 | 178.879 | 178.679 | 0.179 | 0.277 | 0.001 |
Total Assets
| 8.471 | 14.11 | 14.43 | 42.367 | 180.451 | 179.725 | 179.777 | 0.18 | 0.301 | 0.025 |
Liabilities & Equity: | ||||||||||
Current Liabilities: | ||||||||||
Account Payables
| 3.311 | 3.146 | 2.017 | 1.653 | 0.71 | 0.163 | 0.121 | 0 | 0.001 | 0.001 |
Short Term Debt
| 1.395 | 1.175 | 0.65 | 0.65 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0.091 | 0.087 | 0.623 | 0.599 | 0.162 | 0.068 | 0.05 | 0 | 0 | 0 |
Deferred Revenue
| -4.706 | -4.321 | 0 | 0 | 0.021 | 0.087 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 4.709 | 0.003 | 0.003 | 27.846 | 0.003 | 0.003 | 0.003 | 0 | 0.276 | 0 |
Total Current Liabilities
| 4.801 | 4.411 | 3.293 | 30.748 | 0.876 | 0.234 | 0.175 | 0 | 0.277 | 0.001 |
Non-Current Liabilities: | ||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 9.15 | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 | 0.009 | 0 | 0 |
Total Non-Current Liabilities
| 9.15 | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 | 0.009 | 0 | 0 |
Total Liabilities
| 13.951 | 13.561 | 12.443 | 39.898 | 10.026 | 9.384 | 9.325 | 0.009 | 0.277 | 0.001 |
Equity: | ||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 8.288 | 13.841 | 13.566 | 13.225 | 179.483 | 178.501 | 178.501 | 0.179 | 0 | 0 |
Retained Earnings
| -13.768 | -13.292 | -11.579 | -10.756 | -9.058 | -8.16 | -8.048 | -0.008 | -0.001 | -0.001 |
Accumulated Other Comprehensive Income/Loss
| 8.288 | 13.841 | 13.566 | 13.225 | 179.483 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| -8.288 | 0 | 0 | 0 | 0 | 0 | 0 | 7.484 | 0.025 | 0.025 |
Total Shareholders Equity
| -5.48 | 0.549 | 1.987 | 2.469 | 170.425 | 170.341 | 170.452 | -0.008 | 0.024 | 0.024 |
Total Equity
| -5.48 | 0.549 | 1.987 | 2.469 | 170.425 | 170.341 | 170.452 | 0 | 0 | 0 |
Total Liabilities & Shareholders Equity
| 8.471 | 14.11 | 14.43 | 42.367 | 180.451 | 179.725 | 179.777 | 0.002 | 0.301 | 0.025 |